NP90726m Vedolizumab (Entyvio®)

A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND)

Source
Find a Tender
Type
Framework (Supply)
Duration
not specified
Value
£48M
Sector
HEALTH
Published
25 Jun 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 1 suppliers

Description

Supply of Vedolizumab (Entyvio®) to NHS Scotland.

Total Quantity or Scope

The Framework Agreement is for the supply of Vedolizumab (Entyvio®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participants.

Award Detail

1 Takeda (London)
  • Value: £47,898,609

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twelve (12) month Framework Agreement duration and the thirty six (36) month optional extension period of the Framework Agreement NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=835484. (SC Ref:835484)

Reference

  • FTS 059697-2026

Domains